Literature DB >> 20532810

Oligodendroglial hamartoma: a potential source of misdiagnosis for oligodendroglioma.

Gianluca Marucci1, Marco Giulioni, Matteo Martinoni, Lilia Volpi, Roberto Michelucci.   

Abstract

Various subtypes of intracerebral hamartomas, associated with seizure disorders, have long been described. We describe a cerebral hamartoma placed in the left frontal lobe, associated with drug-resistant epilepsy, composed exclusively of mature oligodendroglial cells. The patient was a 27-year-old right-handed male presenting with severe epileptic encephalopathy and symptoms of behavior dysfunction (disinhibition, rage attacks) associated with a left frontal lesion. Magnetic resonance imaging revealed a small area iso-hypointense compared to the gray matter in T1-weighted sequences not enhancing after gadolinium contrast injection in the left frontal site. On histology, a cortical lesion composed of large aggregates of oligodendroglial cells, with round central nuclei and clear perinuclear halos, was observed. Neither mitotic figures nor necrosis were present. Reactivity for Ki67 and P53 was not found. The lesion was well demarcated from the adjacent brain parenchyma and perineuronal satellitosis was not observed in the cortex. In conclusion, albeit extremely rare, recognition of oligodendroglial hamartoma and its distinction from other epileptogenic lesions as dysembryoplastic neuroepithelial tumor or above all oligodendroglioma have important therapeutic and prognostic implications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20532810     DOI: 10.1007/s11060-010-0253-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  10 in total

Review 1.  Current concepts in the evaluation and management of WHO grade II gliomas.

Authors:  Joseph M Piepmeier
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

Review 2.  Current diagnosis and treatment of oligodendroglioma.

Authors:  Herbert H Engelhard
Journal:  Neurosurg Focus       Date:  2002-02-15       Impact factor: 4.047

3.  Spinal cord hamartoma: case report.

Authors:  K Riley; C A Palmer; A B Oser; C G Paramore
Journal:  Neurosurgery       Date:  1999-05       Impact factor: 4.654

4.  Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study.

Authors:  Alba A Brandes; Alicia Tosoni; Giovanna Cavallo; Michele Reni; Enrico Franceschi; Laura Bonaldi; Roberta Bertorelle; Marina Gardiman; Claudio Ghimenton; Paolo Iuzzolino; Annalisa Pession; Valeria Blatt; Mario Ermani
Journal:  J Clin Oncol       Date:  2006-09-05       Impact factor: 44.544

5.  Hamartomas in the setting of chronic epilepsy: a clinicopathologic study of 13 cases.

Authors:  E E Volk; R A Prayson
Journal:  Hum Pathol       Date:  1997-02       Impact factor: 3.466

6.  Malignant transformation of a dysembryoplastic neuroepithelial tumor. Case report.

Authors:  R R Hammond; N Duggal; J M Woulfe; J P Girvin
Journal:  J Neurosurg       Date:  2000-04       Impact factor: 5.115

7.  Surgical pathology of chronic epileptic seizure disorders: experience with 63 specimens from extratemporal corticectomies, lobectomies and functional hemispherectomies.

Authors:  H K Wolf; J Zentner; A Hufnagel; M G Campos; J Schramm; C E Elger; O D Wiestler
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 8.  Clinicopathologic features of recurrent dysembryoplastic neuroepithelial tumor and rare malignant transformation: a report of 5 cases and review of the literature.

Authors:  Wilson Z Ray; Spiros L Blackburn; Sandro Casavilca-Zambrano; Carlos Barrionuevo; Jose E Orrego; Hugo Heinicke; Joshua L Dowling; Arie Perry
Journal:  J Neurooncol       Date:  2009-03-08       Impact factor: 4.130

9.  Surgical treatment of temporal lobe epilepsy: clinical, radiological, and histopathological findings in 178 patients.

Authors:  J Zentner; A Hufnagel; H K Wolf; B Ostertun; E Behrens; M G Campos; L Solymosi; C E Elger; O D Wiestler; J Schramm
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-06       Impact factor: 10.154

10.  Oligodendroglial hamartoma of the right temporal lobe: a case report and discussion of possible histogenesis.

Authors:  E Tasdemiroglu; M Nazek; M Zuccarello
Journal:  Clin Neuropathol       Date:  1994 Jul-Aug       Impact factor: 1.368

  10 in total
  5 in total

Review 1.  Multifocal presentation of medulloblastoma in adulthood.

Authors:  Pietro Ciccarino; Antonino Rotilio; Marta Rossetto; Renzo Manara; Enrico Orvieto; Franco Berti; Giuseppe Lombardi; Domenico d'Avella; Renato Scienza; Alessandro Della Puppa
Journal:  J Neurooncol       Date:  2011-11-10       Impact factor: 4.130

2.  MRI, Magnetoencephalography, and Surgical Outcome of Oligodendrocytosis versus Focal Cortical Dysplasia Type I.

Authors:  D Mata-Mbemba; Y Iimura; L-N Hazrati; A Ochi; H Otsubo; O C Snead; J Rutka; E Widjaja
Journal:  AJNR Am J Neuroradiol       Date:  2018-11-15       Impact factor: 3.825

3.  Bilateral oligodendroglial hamartomas: A rare cause of drug-resistant epilepsy in a pediatric patient.

Authors:  Havisha Munjal; Devanshi Mistry; Jeevak Almast; Shehanaz Ellika
Journal:  J Clin Imaging Sci       Date:  2022-05-05

4.  Epileptic Patient with Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia and Epilepsy (MOGHE): A Case Report and Review of the Literature.

Authors:  A Verentzioti; I Blumcke; A Alexoudi; P Patrikelis; A Siatouni; S Korfias; D Sakas; S Gatzonis
Journal:  Case Rep Neurol Med       Date:  2019-06-09

5.  Cerebral astroblastoma with oligodendroglial-like cells: A case report.

Authors:  Jian Gu; Yihua Wang; Juanhan Yu
Journal:  Medicine (Baltimore)       Date:  2021-10-29       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.